Product Information
PHENTERMINE 30 MG CAPSULE is a generic product labeled by Aurolife Pharma LLC, priced at $0.1149 per EA under NDC 13107010601. Its NADAC has been published 419 times since Aug 16, 2017.
Strength
30 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107010601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204318On Market Since
3/20/2017
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 30 MG CAPSULE has been published 419 times since Aug 16, 2017, and over the history we have for it it has declined 45.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1149 per EA |
|---|---|
| All-time high | $0.2089 (Aug 16, 2017) |
| All-time low | $0.1044 (Jul 17, 2024) |
| 52-week high | $0.1263 |
| 52-week low | $0.1149 |
| Median price | $0.1473 |
| Average price | $0.1476 |
| Largest weekly change | +58.1% (Mar 20, 2024) |
| Weeks tracked | 419 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 30 MG CAPSULE, manufactured by Aurolife Pharma LLC, is $0.1149 per EA (NDC 13107010601), effective Aug 20, 2025.
How has the price of PHENTERMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 30 MG CAPSULE has declined 45.0%. It has been tracked across 419 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 30 MG CAPSULE?
Since Aug 16, 2017, the NADAC for PHENTERMINE 30 MG CAPSULE has ranged from a low of $0.1044 (Jul 17, 2024) to a high of $0.2089 (Aug 16, 2017), with a median of $0.1473 per EA.
Are there cheaper alternatives to PHENTERMINE 30 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 30 MG CAPSULE, is $0.1044 per EA — about 9% below PHENTERMINE 30 MG CAPSULE.
Who manufactures PHENTERMINE 30 MG CAPSULE?
PHENTERMINE 30 MG CAPSULE (NDC 13107010601) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification